Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 74-3223951 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Drug Research for Neglected Diseases and Mental Health for Opioid/Substance Use Disorder (OUD/SUD) and Antiaddiction product Ibogaine in preparation for FDA Investigative New Drug Development for Opioid Abatement program in NYS. KRFI has prepared the Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga Drug Master Files IP provision for Private Public Sector Partnership for health equity, accessibility through the Clinical Trial Management Platform and drug supply chain security hyperledger.
Total Revenue
$90K
FY2022
Total Expenses
$44K
FY2022
Net Assets
$60K
Program Ratio
—
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.